CA
NZ
UK
AU
IND
US
Krystal is a commercial-stage company that develops gene therapies, and Vyjuvek treats dystrophic epidermolysis bullosa, a rare genetic skin disease. US net revenue was $95.3 million, supported by more than 760 reimbursement approvals and over 80 new prescribers added in the quarter. About 80% …
Management said FPGA revenue grew about 90% year over year, fueled by data center AIDemandand a recovery in industrial and embedded markets. Compute and Communications revenue reached $171.9 million, up from $74.0 million a year earlier, a gain of about 132% (calculated). Industrial and …
For the first nine months, net income was $1,087 million, or $5.29 per share, versus $1,265 million, or $6.03. The weighted average diluted share count declined to 204.57 million in the quarter from 207.71 million.
Lumentum makes lasers, modules and optical subsystems used inData Centerconnectivity, telecom networks, industrialManufacturingand sensing. Management said growth came across all businesses, led by pump lasers and optical circuit switches (OCS), and that cloud modules improved on the gross margin line.
Management said global RevPAR rose 6.5%, with the U.S. and Canada up 7.4%, or 6.2% excluding World Cup markets. Luxury RevPAR gained 12% and select service rose over 6%. Leisure RevPAR increased 7% globally.
Net income was $174.4 million versus $160.7 million, andOperating Incomewas $268.6 million versus $221.3 million. Adjusted EBITDA was $344 million, up 14%, but the prior-year quarter included a $61 million legal settlement charge. Excluding that charge, adjusted EBITDA fell 5%, mainly on higherMarketingspend at …
Adjusted net income was $14.9 million, or $0.35 per share, versus $11.8 million, or $0.27, a year ago. Adjusted results exclude a pre-tax gain of $15.7 million from remeasuring benefit plans. Adjusted EBITDA was $34.5 million, compared with $29.0 million in both the prior …
MSA is a global provider of industrial safety technology that protects people andFacilityinfrastructure, with gas detection, fire service and industrial protection lines. Detection sales rose 22% to $233.9 million, but only 2% organically. Fire Service gained 9% to $173.2 million, all organic, and Industrial …
The company designs and manufactures electronic security devices, including access control, door-locking, intrusion and fire alarm products, and sells cellular communication services for alarm systems. It sells mainly through independent distributors, dealers and installers.
Neurocrine is a biopharmaceutical company focused on neurology, psychiatry and endocrinology. INGREZZA, its treatment for tardive dyskinesia, generated $801.5 million, up from $686.6 million, on record new and total prescriptions. CRENESSITY, approved for classic congenital adrenal hyperplasia, more than doubled to $210.8 million, and …
Please wait processing your request...